These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 19318051)
1. Morphological study on Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105). Uenishi Y; Kawabe K; Nomura T; Nakai M; Sunagawa M J Microbiol Methods; 2009 May; 77(2):139-44. PubMed ID: 19318051 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of mycolic acid subclass and molecular species composition of Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105). Uenishi Y; Fujita Y; Kusunose N; Yano I; Sunagawa M J Microbiol Methods; 2008 Feb; 72(2):149-56. PubMed ID: 18178279 [TBL] [Abstract][Full Text] [Related]
3. Isolation and identification of arabinose mycolates of Cell Wall Skeleton (CWS) derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105). Uenishi Y; Kusunose N; Yano I; Sunagawa M J Microbiol Methods; 2010 Mar; 80(3):302-5. PubMed ID: 20079769 [TBL] [Abstract][Full Text] [Related]
4. Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models. Miyauchi M; Murata M; Fukushima A; Sato T; Nakagawa M; Fujii T; Koseki N; Chiba N; Kashiwazaki Y Drug Discov Ther; 2012 Aug; 6(4):218-25. PubMed ID: 23006993 [TBL] [Abstract][Full Text] [Related]
5. Separation and molecular characterization of mycolic acid from the cell wall skeleton of Mycobacterium bovis BCG Tokyo 172 (SMP-105) and BCG substrains by normal-phase high performance liquid chromatography and liquid chromatography/mass spectrometry. Uenishi Y; Takii T; Yano I; Sunagawa M J Microbiol Methods; 2009 Jun; 77(3):320-2. PubMed ID: 19328829 [TBL] [Abstract][Full Text] [Related]
6. Study on the cell wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105): establishment of preparation and analytical methods. Uenishi Y; Okada T; Okabe S; Sunagawa M Chem Pharm Bull (Tokyo); 2007 Jun; 55(6):843-52. PubMed ID: 17541180 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and TNF-alpha inducing activities of mycoloyl-arabinan motif of mycobacterial cell wall components. Ishiwata A; Akao H; Ito Y; Sunagawa M; Kusunose N; Kashiwazaki Y Bioorg Med Chem; 2006 May; 14(9):3049-61. PubMed ID: 16426852 [TBL] [Abstract][Full Text] [Related]
8. Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy. Ishii K; Kurita-Taniguchi M; Aoki M; Kimura T; Kashiwazaki Y; Matsumoto M; Seya T Immunol Lett; 2005 May; 98(2):280-90. PubMed ID: 15860229 [TBL] [Abstract][Full Text] [Related]
9. Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors. Murata M Cancer Sci; 2008 Jul; 99(7):1435-40. PubMed ID: 18452561 [TBL] [Abstract][Full Text] [Related]
10. Chemical structure of the cell wall of Mycobacterium tuberculosis var. bovis, strain BCG. Petit JF; Wietzerbin J; Das BC; Lederer E Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):118-25. PubMed ID: 126548 [TBL] [Abstract][Full Text] [Related]
11. Surface morphology of Mycobacterium bovis BCG: relation to mechanisms of cellular aggregation. Devadoss P; Klegerman ME; Groves MJ Microbios; 1991; 65(263):111-25. PubMed ID: 2023544 [TBL] [Abstract][Full Text] [Related]
12. Chemical and ultrastructural investigations of Mycobacterium bovis BCG: implications for the molecular structure of the mycobacterial cell envelope. Klegerman ME; Devadoss PO; Garrido JL; Reyes HR; Groves MJ FEMS Immunol Med Microbiol; 1996 Oct; 15(4):213-22. PubMed ID: 8908482 [TBL] [Abstract][Full Text] [Related]
13. Ultrastructural characteristics of Mycobacterium bovis BCG and Mycobacterium leprae. Binkhuysen F; Das PK Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):76-82. PubMed ID: 7042614 [TBL] [Abstract][Full Text] [Related]
14. Bacillus calmette-guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy. Yuk JM; Shin DM; Song KS; Lim K; Kim KH; Lee SH; Kim JM; Lee JS; Paik TH; Kim JS; Jo EK Autophagy; 2010 Jan; 6(1):46-60. PubMed ID: 19901560 [TBL] [Abstract][Full Text] [Related]
15. Arabino-mycolates derived from cell-wall skeleton of Mycobacterium bovis BCG as a prominent structure for recognition by host immunity. Miyauchi M; Murata M; Shibuya K; Koga-Yamakawa E; Uenishi Y; Kusunose N; Sunagawa M; Yano I; Kashiwazaki Y Drug Discov Ther; 2011 Jun; 5(3):130-5. PubMed ID: 22466242 [TBL] [Abstract][Full Text] [Related]
16. Development of immunoadjuvants for immunotherapy of cancer. Azuma I; Seya T Int Immunopharmacol; 2001 Jul; 1(7):1249-59. PubMed ID: 11460306 [TBL] [Abstract][Full Text] [Related]
17. Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology. Masuda H; Nakamura T; Noma Y; Harashima H Mol Pharm; 2018 Dec; 15(12):5762-5771. PubMed ID: 30380885 [TBL] [Abstract][Full Text] [Related]
19. [Antitumor activity of bacterial fractions and related synthetic compounds]. Azuma I; Yamamura Y Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2691-9. PubMed ID: 6508322 [TBL] [Abstract][Full Text] [Related]